Follow the MiniMed Group, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €2bn. The latest transaction was reported on 6 July 2026 (Attribution). Among the most active insiders: Chandrasena Gillian. Every trade is openly available.
10
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate MiniMed Group, Inc. Strong Buy (bullish), based on 11 analysts. Average price target: US$56.64.
36Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
MiniMed Group, Inc. is a NASDAQ-listed company that specializes in developing technologies for diabetes management. It focuses on glucose monitoring systems and insulin pumps.